Tagged Premiums

Best Reads Of The Week With Brianna Labuskes

Happy Friday! Ending a week in which I’ve been wondering if we all have been dropped into the first act of a supervillain movie since the news that the mysterious brain-injury-caused-by-sound has seemingly spread from Cuba into China.

Here’s some other whodunits — health policy thrillers, right? — for this three-day weekend.

Lawmakers were busy: Ahead of Memorial Day, the Senate sent a bill that would overhaul the VA health system and expand the Choice Program to President Donald Trump. While the legislation sailed through the chambers, critics say it’s too drastic a move toward privatized care, a hot-button topic that’s not going anywhere soon (especially with the Koch brothers’ billions behind it). On the other side of the building, the House approved a “right-to-try” bill (… coincidentally also backed by the Koch brothers … ), reviving the measure that had stuttered over the past few months.

• The New York Times: Senate Sends Major Overhaul of Veterans Health Care to Trump

• The Associated Press: Congress OKs Letting Terminal Patients Try Unapproved Drugs

Consider: $685 billion a year. That’s what it costs taxpayers to make health care affordable for Americans, and the price tag is expected to nearly double in the next decade. So, while some Republicans are refusing to touch a fresh attempt at repeal with a 10-foot pole this close to the midterms, others are trying to reclaim the topic that’s clearly going to be at the top of voters’ minds. High premium increases loom large in the next few months as each side races to control the conversation.

• The Wall Street Journal: New Push to Topple Affordable Care Act Looms 

• Bloomberg: It Costs $685 Billion a Year to Subsidize U.S. Health Insurance

And, for what it’s worth, despite Republicans’ attempts to chip away at the health law, the uninsured rate held pretty steady last year.

• The New York Times: Despite Attacks on Obamacare, the Uninsured Rate Held Steady Last Year

Requiring pharma companies to list their drugs’ prices in ads seems like a simple request. As with most things in the dark and confusing labyrinth that is the drug-cost pipeline, though, it’s a bit more complicated. The proposal, which is part of Trump’s blueprint to lower prices, at first seemed like an idle threat. But HHS Secretary Alex Azar keeps bringing it up. Companies are getting nervous, and are left asking — would the rule even be legal?

• The New York Times: Requiring Prices in Drug Ads: Would It Do Any Good? Is It Even Legal?

Adding work requirements to states’ Medicaid programs may be the hot new trend, but a new report shows that it will cost states and the government tens of millions of dollars. And despite garnering savings in the long-run, that money will come entirely from people losing coverage and access to care. On the flip side of things, red states are getting a serious reality check on just how far they can go with changes to their programs.

• Modern Healthcare: States Face Big Costs, Coverage Losses From Medicaid Work Requirements

• The Hill: Red States Find There’s No Free Pass on Medicaid Changes From Trump

The miscellaneous file is bursting with must-read stories, so it’s lucky there’s an extra day in the weekend to fit them all in: Patients addicted to opioids were promised free rehab but were instead put to work 16 hours a day for no pay at adult care homes changing diapers and dispensing medication; some new mothers in China are being forced to pay their medical bills before they’re allowed to see their babies; depression medication, insulin and birth control are ending up in our rivers and streams from poor wastewater disposal practices; scientists are on tenterhooks as they watch the effectiveness of the new Ebola vaccine play out in real time; and a captivating profile surfaced on a doctor who has been accused of putting his quest to make history ahead of the needs of some patients.

• Reveal: Drug Users Got Exploited. Disabled Patients Got Hurt. One Woman Benefited From It All

• Stat: Pharmaceutical Manufacturing Plants Are Sending Lots of Medicine Into the Water Supply

• The New York Times: Want to See Your Baby? In China, It Can Cost You

• The Washington Post: New Ebola Vaccine Faces Major Test in Congo Outbreak

• ProPublica: A Pioneering Heart Surgeon’s Secret History of Research

And make sure you’re following the L.A. Times’ comprehensive coverage of the controversy at the University of Southern California —

• Los Angeles Times: Students Warned USC About Gynecologist Early in His Career: ‘They Missed an Opportunity to Save a Lot of Other Women’

Have a great holiday weekend, and if you’re planning on soaking up any rays, stick with lotion instead of trying any of those sunscreen pills.

Best Reads Of The Week With Brianna Labuskes

From nursing home bullies to do-it-yourself gene editing in teenagers’ garages, this week was a wild — or should we say “royal” in anticipation of a certain big event across the Atlantic — ride in health news. So, buckle up, here’s what you might have missed.

This is the story that you’ll get sick of reading over the next six months, but it’s important because you can bet that the rising health law premiums will play a big role in the midterms. The only question is: Who’s going to win the blame game? As the first glimpse of sky-high rate hikes come out, Democrats are eager to point fingers, but Republicans say their liberal colleagues should “look in the mirror” when it comes to assigning responsibility.

• The Hill: Premium Hikes Reignite the ObamaCare Wars

In a decision that was expected, the Trump administration is resurrecting a Reagan-era policy that would add abortion restrictions to federally funded family planning programs. Abortion advocates say the policy — which they call a domestic “gag order — puts government into the middle of the doctor-patient relationship. But the other side sees it as another victory from an administration that is living up to its campaign promises.

• The Associated Press: Trump to Deny Funds to Clinics That Discuss Abortion

Pharma remained in the spotlight this week after all the attention from President Donald Trump’s plan to curb high drug costs, announced last Friday. While HHS Secretary Alex Azar is busy adamantly defending that blueprint, the Food and Drug Administration is naming names of companies accused of hindering generics development, in hopes that public shaming can get some bad actors to “end their shenanigans.” Celgene is one of those drugmakers in the hot seat.

• The Associated Press: FDA Names Drugmakers Accused of Blocking Cheaper Generics

• NPR: Celgene’s Patent Fortress Protects Revlimid, Thalomid

And you know how Viagra was a happy accident? Well, researchers want fewer oopsie successes and more that are deliberately planned.

 • The Washington Post: Viagra and Many Other Drugs Were Discovered by Chance. Now Science Is Hoping to Change That.

It was a good week to keep an eye on the states. Up in Vermont, the governor signed legislation that could allow the state to import drugs from Canada. HHS still has to approve the policy, though, and since Azar has called the tactic “a gimmick,” there’s no sure bet that it will move forward. The health world’s eyes are also on the state because its experimental plan to control costs is going to come within 1 percent of its financial target. An “impressive” feat, experts say.

• Politico: Vermont Becomes First State to Permit Drug Imports From Canada

• The Associated Press: Eyes Turn to Vermont As It Sees Success With Health System

And Maryland remains on the forefront of innovative thinking to control costs with the approval of its unique all-payer model.

• The Associated Press: Maryland Announces Agreement on All-Payer Health Model

“It’s one of the big demographic mysteries of recent times,” fertility experts say of the nation’s record-low birth rate for the second year in a row. Researchers aren’t sure why the numbers haven’t increased along with the improved economy as would be expected. But some suspect that younger women are putting off having babies as they focus on their careers.

• The New York Times: U.S. Fertility Rate Fell to a Record Low, for a Second Straight Year

And this doctor is pushing the boundaries of what is considered possible in fertility research with “three-parent babies” — sparking talk of sci-fi dystopian worlds. But critics worry there’s no oversight to stop the slide down the slippery slope of tinkering with human life.

• The Washington Post: Fertility Doctor John Zhang Pushes Boundaries in Human Reproduction

In the miscellaneous gotta-read files: An in-depth investigation reveals just how far a center once renowned for its heart transplant program has fallen; a tragic suicide sparks debate over whether colleges should tell parents when students are struggling; what the president’s proposed border wall means for a community burdened by extremely poor health; and a keyless ignition jaw-dropper. People are leaving their cars in the garage — not realizing the motors are still running — and suffering fatal consequences.

• ProPublica: At St. Luke’s in Houston, Patients Suffer As a Renowned Heart Transplant Program Loses Its Luster

• The New York Times: His College Knew of His Despair. His Parents Didn’t, Until It Was Too Late.

• The Wall Street Journal: Youth Suicidal Behavior Is on the Rise, Especially Among Girls

• US News & World Report: A Battle for Community Health in Texas’ Rio Grande Valley

• The New York Times: Deadly Convenience: Keyless Cars and Their Carbon Monoxide Toll

Have a great weekend!